Warberg Asset Management’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-28,450
Closed -$7K 327
2022
Q2
$7K Hold
28,450
﹤0.01% 226
2022
Q1
$11K Buy
+28,450
New +$9.19K ﹤0.01% 202
2021
Q4
Sell
-18,450
Closed -$9K 234
2021
Q3
$9K Sell
18,450
-14,450
-44% -$7.1K ﹤0.01% 192
2021
Q2
$19K Sell
32,900
-4,100
-11% -$2.75K ﹤0.01% 190
2021
Q1
$32K Sell
37,000
-17,000
-31% -$14.5K 0.01% 140
2020
Q4
$10K Buy
+54,000
New +$18.2K ﹤0.01% 151

Other funds holding MDGSW

Warberg Asset Management's MDGSW Position: Q3 2022 in Review

Warberg Asset Management sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q3 2022, closing a stake of 28,450 shares — an estimated $7K sold.

Warberg Asset Management first reported a position in MDGSW in Q4 2020 and held it in 6 quarters. The position peaked at $32K in Q1 2021. 5 funds tracked by Wall St. Rank hold MDGSW as of Q3 2022.

  • Warberg Asset Management reported no remaining Medigus Ltd. Series C Warrant position as of Q3 2022 after selling out during the quarter.
  • Warberg Asset Management sold 28,450 Medigus Ltd. Series C Warrant shares in Q3 2022, an estimated $7K.
  • Warberg Asset Management first reported a position in Medigus Ltd. Series C Warrant in Q4 2020 and held it in 6 quarters.
  • Warberg Asset Management's Medigus Ltd. Series C Warrant position peaked at $32K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q3 2022.

Based on Warberg Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.